» Articles » PMID: 9017779

Warfarin-fluoxetine and Diazepam-fluoxetine Interaction

Overview
Journal Pharmacotherapy
Specialty Pharmacology
Date 1997 Jan 1
PMID 9017779
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Fluoxetine and its metabolite norfluoxetine are eliminated by oxidative metabolism via the CYP450 system and may inhibit the oxidative metabolism of other drugs to various degrees. A fluoxetine-warfarin interaction has been postulated, but is not well documented in the literature. The elimination of diazepam may also be inhibited by fluoxetine. An elderly man was prescribed these three drugs in combination and experienced such an interaction. He developed an elevated international normalized ratio (INR) and died from a cerebral hemorrhage. He also manifested drug delirium secondary to inhibited diazepam metabolism. In elderly patients receiving fluoxetine, lorazepam or oxazepam would be safer alternatives to diazepam since they are conjugated in the liver. Patients stabilized on warfarin should be monitored closely for changes in INR if fluoxetine is added or deleted.

Citing Articles

SSRI co-medication with NOAC or VKA does not increase hospitalisation for bleeding: A retrospective nationwide cohort study in Austria 2010-2015.

Sheikh Rezaei S, Mittlbock M, Reichardt B, Wolzt M Int J Geriatr Psychiatry. 2019; 34(8):1194-1199.

PMID: 30968457 PMC: 6767374. DOI: 10.1002/gps.5117.


Bupropion-warfarin combination: a serious complication.

Bavle A, Phatak A Indian J Psychol Med. 2013; 35(3):311-3.

PMID: 24249938 PMC: 3821213. DOI: 10.4103/0253-7176.119488.


Clinically significant drug interactions with newer antidepressants.

Spina E, Trifiro G, Caraci F CNS Drugs. 2011; 26(1):39-67.

PMID: 22171584 DOI: 10.2165/11594710-000000000-00000.


Selective serotonin re-uptake inhibiting antidepressants and the risk of overanticoagulation during acenocoumarol maintenance treatment.

Teichert M, Visser L, Uitterlinden A, Hofman A, Buhre P, Straus S Br J Clin Pharmacol. 2011; 72(5):798-805.

PMID: 21545482 PMC: 3243014. DOI: 10.1111/j.1365-2125.2011.04004.x.


Safety of selective serotonin reuptake inhibitor use prior to coronary artery bypass grafting.

Xiong G, Jiang W, Clare R, Shaw L, Smith P, OConnor C Clin Cardiol. 2010; 33(6):E94-8.

PMID: 20552618 PMC: 6653610. DOI: 10.1002/clc.20621.